Abdulkadir S A, Ono S J
Department of Medicine, Lucille P. Markey Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
FASEB J. 1995 Nov;9(14):1429-35. doi: 10.1096/fasebj.9.14.7589984.
Fragments of foreign antigen are detected by CD4+ helper T cells via the T cell receptor for antigen in the context of major histocompatibility complex (MHC) class II molecules. Very few cells normally express class II MHC molecules, and these cells play critical roles in antigen presentation and in the thymic selection of T lymphocytes before their exit into the periphery. Because of the central role the class II MHC molecules play in immune system function, it is not surprising that the lack of expression of these molecules results in a severe combined immunodeficiency disorder (called bare lymphocyte syndrome) and that the aberrant expression of the molecules is frequently observed in the target organs of various autoimmune disorders (e.g., multiple sclerosis and rheumatoid arthritis). Because both classes of disease could conceivably be treated by molecular approaches targeted at either restoring or inhibiting expression of class II MHC genes, there has been an intense effort during the past decade to elucidate the regulatory mechanisms of class II MHC genes. An analysis of recent advances in this effort is provided in this review article.
在主要组织相容性复合体(MHC)II类分子的背景下,CD4 +辅助性T细胞通过抗原特异性T细胞受体检测外来抗原片段。正常情况下,很少有细胞表达II类MHC分子,这些细胞在抗原呈递以及T淋巴细胞进入外周之前的胸腺选择过程中发挥关键作用。由于II类MHC分子在免疫系统功能中发挥核心作用,因此这些分子表达缺失导致严重联合免疫缺陷疾病(称为裸淋巴细胞综合征)并不奇怪,并且在各种自身免疫性疾病(如多发性硬化症和类风湿性关节炎)的靶器官中经常观察到这些分子的异常表达。由于这两类疾病都可以通过针对恢复或抑制II类MHC基因表达的分子方法进行治疗,因此在过去十年中人们一直在努力阐明II类MHC基因的调控机制。本文对这一研究进展进行了分析。